Generic drug
Moxifloxacin price, strengths & recalls
Generic of Vigamox
Pharmacies pay $42.67 for 30 tablets of Moxifloxacin 400 mg tablet this week, and from $4.99 to $42.67 across its 2 priced strengths and forms. 37 manufacturers make it. 14 recalls are ongoing. Its official label last changed on July 19, 2024.
14 open recallsGeneric- Fair cash price
- $59.57
- Strengths
- 2
- Makers
- 37
- Updated
- Nov 11
Moxifloxacin price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 5 mg/mL eye drops | $1.66 | $4.99 / 3 mL | ||
| 1.6 mg/mL, 250 mL injection | Not priced this week | |||
| 400 mg tablet | $1.42 | $42.67 / 30 tablets | ||
Brand names of moxifloxacin
A brand and its generic share the active ingredient; the generic is almost always far cheaper.
Supply status: shortages & recalls
Recalls
Showing the 6 most relevant of 39 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Moxifloxacin
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use MOXIFLOXACIN INJECTION safely and effectively. See full prescribing information for MOXIFLOXACIN INJECTION.MOXIFLOXACIN injection, for intravenous use Initial U.S. Approval: 1999 To reduce the development of drug-resistant bacteria and maintain the effectiveness of moxifloxacin injection and other antibacterial drugs, moxifloxacin injection should be used only to treat or prevent infections that are proven or strongly suspected to
WARNING: SERIOUS ADVERSE REACTIONS INCLUDING TENDINITIS, TENDON RUPTURE, PERIPHERAL NEUROPATHY, CENTRAL NERVOUS SYSTEM EFFECTS and EXACERBATION OF MYASTHENIA GRAVIS
Fluoroquinolones, including moxifloxacin, have been associated with disabling and potentially irreversible serious adverse reactions that have occurred together
[see
Warnings and Precautions (5.1)]
, including:
Tendinitis and tendon rupture
[see
Warnings and Precautions (5.2)]
Peripheral neuropathy
[see
Warnings and Precautions (5.3)]
Central nervous system effects
[see
Warnings and Precautions (5.4)]
Discontinue moxifloxacin immediately and avoid the use of fluoroquinolones, including moxifloxacin, in patients who experience any of these serious adverse reactions
[see
Warnings and Precautions (5.1)]
.
Fluoroquinolones, including moxifloxacin, may exacerbate muscle weakness in patients with myasthenia gravis. Avoid moxifloxacin in patients with known history of myasthenia gravis
[see
Warnings and Precautions (5.5)]
.
Because fluoroquinolones, including moxifloxacin, have been associated with serious adverse reactions
[see
Warnings and Precautions (5.1 to 5.13)]
, reserve moxifloxacin for use in patients who have no alternative treatment options for the following indications:
Acute sinusitis
[see Indications and Usage (1.5)]
Acute bacterial exacerbation of chronic bronchitis
[see
Indications and Usage (1.6)]
WARNING: SERIOUS ADVERSE REACTIONS INCLUDING TENDINITIS, TENDON RUPTURE, PERIPHERAL NEUROPATHY, CENTRAL NERVOUS SYSTEM EFFECTS and EXACERBATION OF MYASTHENIA GRAVIS
See full prescribing Information for complete boxed warning
Fluoroquinolones, including moxifloxacin, have been associated with disabling and potentially irreversible serious adverse reactions that have occurred together (5.1) including:
Tendinitis and tendon rupture (5.2)
Peripheral neuropathy (5.3)
Central nervous system effects (5.4)
Discontinue moxifloxacin injection immediately and avoid the use of fluoroquinolones, including moxifloxacin, in patients who experience any of these serious adverse reactions.
Fluoroquinolones, including moxifloxacin, may exacerbate muscle weakness in patients with myasthenia gravis. Avoid moxifloxacin in patients with known history of myasthenia gravis (
5.5).
Because fluoroquinolones, including moxifloxacin, have been associated with serious adverse reactions (5.1 to 5.13), reserve moxifloxacin for use in patients who have no alternative treatment options for the following indications:
Acute bacterial sinusitis (1.5)
Acute bacterial exacerbation of chronic bronchitis (1.6)
Recent major changes (as listed on the label)
Boxed Warning 5/2016
Indications and Usage 5/2016
Dosage and Administration 5/2016
Warnings and Precautions 5/2016
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA205572 · Fresenius Kabi USA
- First approved
- April 3, 2015 (11 years ago)
- Latest approved change
- March 27, 2020
- Approved label
- PDF, Mar 31, 2020
- Generic makers
- 18 approved generic applications on the market
Moxifloxacin questions
How much does moxifloxacin cost without insurance?
Pharmacies pay about $42.67 for 30 tablets of moxifloxacin 400 mg tablet ($1.42 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $59.57. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
What is the brand name of moxifloxacin?
Moxifloxacin is sold as Vigamox. The generic has the same active ingredient and usually costs far less.
Is moxifloxacin in shortage?
No shortage is reported for moxifloxacin right now. We check the national shortage list every day.
Has moxifloxacin been recalled?
39 recalls on record, 14 ongoing. Recalls name specific lots - check yours.
When did the moxifloxacin label last change?
The official label was last updated on July 19, 2024 (version 4). See what changed.
Talk about moxifloxacin
No comments yet. Questions, tips, what worked for you - start the conversation.